Cabezas, D.; Delgado, T.; Sepúlveda, G.; Krňávková, P.; Vojáčková, V.; Kryštof, V.; Strnad, M.; Silva, N.I.; Echeverría, J.; Espinosa-Bustos, C.;
et al. 3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib. Pharmaceuticals 2025, 18, 925.
https://doi.org/10.3390/ph18060925
AMA Style
Cabezas D, Delgado T, Sepúlveda G, Krňávková P, Vojáčková V, Kryštof V, Strnad M, Silva NI, Echeverría J, Espinosa-Bustos C,
et al. 3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib. Pharmaceuticals. 2025; 18(6):925.
https://doi.org/10.3390/ph18060925
Chicago/Turabian Style
Cabezas, David, Thalía Delgado, Guisselle Sepúlveda, Petra Krňávková, Veronika Vojáčková, Vladimír Kryštof, Miroslav Strnad, Nicolás Ignacio Silva, Javier Echeverría, Christian Espinosa-Bustos,
and et al. 2025. "3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib" Pharmaceuticals 18, no. 6: 925.
https://doi.org/10.3390/ph18060925
APA Style
Cabezas, D., Delgado, T., Sepúlveda, G., Krňávková, P., Vojáčková, V., Kryštof, V., Strnad, M., Silva, N. I., Echeverría, J., Espinosa-Bustos, C., Mellado, G., Luo, J., Mella, J., & Salas, C. O.
(2025). 3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib. Pharmaceuticals, 18(6), 925.
https://doi.org/10.3390/ph18060925
